CONTENTS.

[CHAPTER I.]
PAGE
Introduction and Nomenclature [1]
[CHAPTER II.]
Nodular Leprosy [5]
Seat, [5]; Localisation, [5]; Affection of the Eyes, [8]; Affection of the Extremities, [10]; Affection of the Mucous Membrane, [11]; Affection of the Lymphatic Glands, [13]; Subcutaneous Nodules, [13]; Affection of Nerves in this Form, [14]; Fate of the Nodules, [15]; Commencement of the Disease, [16]; Duration of the Eruptions, [19]; Fate of the Patient, [19]; Combination with Tuberculosis, [22]; Comparison with that Disease, [23]; Affection of the Lungs, [26]; Cultivation of the Bacilli, [27], Miliary Leprosy, [28]; Mental Symptoms, [29].
[CHAPTER III.]
Structure of the Leproma [31]
Movement of the Bacilli, [31]; Nature of the Cells, [32]; Nature of the Blood Vessels, [32]; Softening of the Nodule, [34]; “Brown Elements,” [34]; “Globi,” [35]; Position of the Bacilli in the Cells, [37]; Position of the Bacilli in the Blood Vessels, [38]; Effect of Measles, [40]; Digestion of the Bacilli by the Cells, [41]; Structure of the Bacilli, [41]; Bacilli in the Sweat Glands, [43]; Affection of the Testicle, [45]; Affection of the Liver, [47]; Affection of the Spleen, [47]; Affection of the Glands, [48]; Affection of the Nerves, [50].
[CHAPTER IV.]
Lepra Maculo-Anæsthetica [52]
Prodromal Stage, [53]; Development of Bullæ, [53]; The Macular Eruption, [54]; Symmetry, [55]; Neuritis, [56]; Trophic Disturbances, [57]; Affections of the Joints, [59]; Motor Weakness, [60]; Atrophy of the Interossei, [61]; Paralysis of the Orbicularis oris et palpebrarum, [61]; Trophic Affections of the Bones and Skin, [62]; Sensation, [64]; Loss of Smell and Taste, [66]; Duration, [66]; Cause of Death, [66]; Recovery, [67].
[CHAPTER V.]
Pathological Anatomy of the Maculo-Anæsthetic Form [68]
Comparison of Recent and Old Macuoles, [68]; Alterations in the Nerves, [70]; Bacilli in the Nerves, [70]; The Spinal Cord, [71]; Lymphatic Glands, [72]; Muscular Affections, [72]; Association with Tuberculosis, [73]; Necrosis of Bones, [75]; Joint Affection, [76]; Difference between the two Forms of the Disease, [77]; Influence of Climate, [79].
[CHAPTER VI.]
Diagnosis and Prognosis [82]
Diagnosis from Psoriasis, [82]; Diagnosis from Syphilis, [83]; Diagnosis from Syringo-myelia, [83]; Leprosy in France, [83]; Morven’s Disease, [83]; Prognosis, [84].
[CHAPTER VII.]
Etiology [86]
Humoral Pathology, [86]; Heredity, [87]; Miasma, [87]; Contagion, [88]; Baumgarten’s Dormant Heredity, [89]; Nature of Heredity, [90]; Father Damien’s Case, [93]; Leprosy among Norwegians in North America, [94]; Inoculation, [95]; Hutchinson’s Fish Theory, [96]; Direct Proofs of Contagion, [97]; Hospital Experience in Norway, [99]; Communication of the Disease, [102]; Greater Danger of Nodular Form, [102]; Leprosy and Vaccination, [103].
[CHAPTER VIII.]
Treatment [105]
Ancient Treatment, [105]; Treatment in the Eighteenth Century, [105]; Specific Remedies—Madar [107], Cashew Oil [107], Gurjun Oil [109], Chaul Moogra [111], Hoang-nan [113], Ussacou [113]; Carbolic Acid, [114]; Creasote, [114]; Phosphorus, [115]; Arsenic, [115]; Ichthyol, [115]; Kreuznach, [115]; Mercury, [116]; Iodine, [116]; Tuberculin, [117]; Chlorate of Potassium, [118]; Hydroxylamin, [118]; Europhen, [119]; Aristol, [120]; Naphthol and Salol, [120]; Methyl Blue, [120]; Nerve Stretching, [120]; Electricity, [121]; Salicylate of Soda, [122]; Importance of Isolation, [124]; Results in Norway, [125].

[TABLES.]

PAGE
[TABLE I.] [128]
The Frequent Complication of Nodular Leprosy with Tuberculosis.
[TABLE II.] [138]
The Proportion of Tuberculosis in Maculo-Anæsthetic Leprosy.
[TABLE III.] [144]
The Proportions of the Two Forms of the Disease in Different Districts.
[TABLE IV.] [145]
The Results of Isolation in Norway.